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Retinoic acid (RA) is known as a teratogen that induces abnormalities in facial structures which are made up mainly of neural crest-derived 
mesenchyme. We investigated expression patterns of RA receptor (RAR) genes (subtypes a, /I. y) during mouse facial development. The expression 
of the RAW gene is specific for the mesenchyme around developing eyes and nose, whereas the RARy gene is expressed in the mesenchyme differen- 
tiating to facial cartilages and bones. In contrast, the RARa gene is expressed weakly and uniformly over the facial region. These results suggest 
that crucial roles of endogenous RA in facial development depend on differential functions of the RAR subtypes. 
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1. INTRODUCTION 
Retinoic acid (RA), a putative morphogen (see [1,2] 
for review), has long been known to be a teratogen in 
human and experimental animals [3-81. In particular, 
RA induces abnormalities in large parts of facial struc- 
tures including the facial skeleton, teeth, and middle 
and external ears [4,6]. It has been demonstrated that 
the facial structures are developed from the cranial 
neural crest cells which have migrated from the head 
neural folds [9] and that exogenous RA inhibits both 
migration of cranial neural crest cells from the cephalic 
neural tube and proliferation and differentiation of 
facial mesenchymal cells [5,7]. Thus, the developmen- 
tal abnormality has been attributed to the perturbation, 
by exogenous RA, of normal differentiation of the 
facial neural crest cells or mesenchyme. It is, hence, ex- 
pected that those neural crest cells and facial mesen- 
chymal cells are targets for RA and both express RA 
receptor (RAR) genes during the period of the facial 
morphogenesis. 
In the present study, we investigated the expression 
pattern of the three subtypes of the RAR gene (mouse 
RARcu, ,B, and y [lo]) during mouse facial development 
by in situ hybridization to identify target cells for en- 
dogenous RA. Since the facial developmental process is 
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very complicated, we summarize the process as follows: 
in 8-g-day-old embryos, the neural crest cells migrate 
from the neural folds to the presumptive facial region 
(reviewed in [9]). In lo-11-day-old embryos, the em- 
bryonic face is composed of a series of small pro- 
minences around the primitive mouth (Fig. 1). These 
facial primordia are made up mainly of mesenchyme 
originating from the cranial neural crest cells. At this 
stage, exogenous RA induces severe defects in the face 
[4]. After 12 days, the neural crest cells differentiate in- 
to the connective tissues (bone, cartilage, and muscle of 
the face), the peripheral nervous system and 
melanocytes. 
2. EXPERIMENTAL 
2.1. Preparation of mouse embryos 
Mouse embryos (C57BL/6) were fixed with 4% paraformaldehyde 
in phosphate-buffered saline (pH 7.4) at 10-13 days post coitum 
(p.c.) (the day of vaginal plug = 0 day). The fixed embryos were 
dehydrated in ethanol series and embedded in paraffin. 
2.2. Probe preparation 
Templates for synthesis of riboprobes for RAR mRNA were con- 
structed by subcloning a fragment (the ligand binding domain) of 
human RARCV cDNA [l l] (cross-hybridized with mouse RARa 
cDNA [ll]) and whole cDNAs of mouse RAM and y (10) into 
pGEM7 vectors (Promega Co.). All cDNAs of RARs were kindly 
donated by Drs Pierre Chambon, Martin Petkovich, and Arthur 
Zelent (CNRS, Strasbourg, France). Both antisense and sense 
riboprobes were labeled with [a-35S]UTP (Amersham Co.). The pro- 
bes were subjected to limited alkaline hydrolysis to shorten them to 
50-150 bases for in situ hybridization. 
71 






Fig. 1. Lateral features of the 11 S-day-old mouse embryo and transverse sections at nasal (a), maxillar (b) and mandibular (c) levels. LNP, lateral 
nasal prominence; MNP, medial nasal prominence; NG, nasal groove; MB, midbrain; FB, forebrain; HB, bindbrain; E, eye; Mx, maxillar 
prominence; Md, mandibular prominence; NT, notocord; TG, trigeminal ganglion. 
Fig. 2. Expression patterns of the RARa, ,8, and y genes in the craniofacial region of the 1 1.5-day-old embryo in transverse sections at nasal 
(top), maxillar (middle), and mandibular (bottom) levels (see Fig. 1). Bright-field micrographs (left) and corresponding dark-field images (right). 
In situ hybridization was performed with the riboprobes for the RARcv (b, f, j), fl (c, g, k), and y (d, h, 1) transcripts. Bar = 5OOpm. 
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2.3. In situ hybridization 
In situ hybridization methods were described previously [12,13]. 
Briefly, 5-,um serial sections were taken on slides coated with poly-L- 
lysine. The slides were hybridized with either antisense or sense 
riboprobe at 50°C for 16 h, washed with 2 x SSC containing 50% 
formamide at 50°C treated with 20pg/ml RNase A, and further 
washed with 0.1 x SSC at 50°C. The slides were dipped in 
photographic emulsion (Kodak NTB2) and exposed for 7-10 days 
before developing in Kodak D19 developer. After staining the slides 
with hematoxylin and eosin, the slides were analyzed on an Olympus 
microscope using bright- and dark-field optics. 
3. RESULTS 
To examine the expression pattern of RAR genes in 
mouse facial development, we performed in situ 
hybridization on serial sections of the developing faces. 
At lo-11 days p.c., although the transcripts of the 
RARa were distributed uniformly in the craniofacial 
region (Fig. 2b, f, j). The RAR,& transcripts were 
observed specifically around developing eyes and 
trigeminal ganglia and also in lateral nasal pro- 
minences, but not in maxilla or mandible (Fig. 2c, g, 
k). In contrast, RARy mRNA was detected in maxilla 
(Fig. 2h), mandible (Fig. 21), and both lateral and 
medial nasal prominences (Fig. 2d). The RAR@ 
transcripts decreased in the anterior region of the 
lateral nasal prominences at 11 days p.c. At 12-13 days 
p.c., the RAR,8 transcripts were confined to the mesen- 
thyme related to the retina, optic nerve and olfactory 
epithelium (Fig. 3b,e). The expression of the RARy 
gene was found in the chondrogenic mesenchyme con- 
densing to differentiate into the nasal and mandibular 
bones (Fig. 3c,f). In this stage, the transcripts of the 
RARa gene were still uniformly distributed in the face 
region (data not shown). 
4. DISCUSSION 
Expression patterns of the RAR genes have been i - 
vestigated in mouse bone [ 131, skin [141, and develop- 
ing limbs [15] by an in situ hybridization method. 
Although the expression of the RAR genes was observ- 
ed in any stage of the developing limb, their expression 
patterns changed drastically with the differentiation 
stage 113-151. Furthermore, the expression patterns of 
Fig. 3 
(hot ta 
. Complementary expression patterns of the RAR,d (b, d, e) and y (a, c, f) genes in the craniofacial region of the 12.5- (top) and 
)m) day-old embryos. Bright-field micrographs (left) and corresponding dark-field images (right). E, eye; NC, nasal cavity; C, chondrc 
mesenchyme. Bar = 5OOrm. 
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the RAR subtype genes differ from each other [15]. 
Reconciliation of the published data with our results 
substantiates general rules for the RAR gene expression 
pattern: (i) the RARc gene is expressed rather weakly 
and uniformly in various tissues; (ii) the RAR,& gene is 
expressed in cells committing programmed cell death 
[15] or cells developing into parts of sensory organs; 
(iii) the RARy gene is expressed in differentiating skin, 
cartilage and bone. 
It is intriguing to note that the expression patterns of 
the RAR,& and y genes at 10-l 1 days p.c. resemble the 
migration patterns of the neural crest cells from 
developing midbrain and anterior hindbrain, respec- 
tively. Morriss-Kay and Tan [16,17] recently in- 
vestigated the pathway of the cranial neural crest cells 
by microinjection of labeled cells into rat embryos in 
vitro and found that (i) the neural crest cells settling to 
form maxillary and mandibular prominences migrate 
from the region of anterior hindbrain, (ii) the cells 
around eyes and trigeminal ganglia migrate from the 
midbrain region, and (iii) the cells migrate both from 
the midbrain and the anterior hindbrain in the facial 
primordia. In the morphogenetic stage (10-l l-day-old 
embryo), we observed the overlapped region where 
both RAR,& and y transcripts are present (Fig. 2), 
although the mesenchymal cells in this area could not 
be distinguished morphologically from those in other 
facial regions. However, in the following differentia- 
tion stage (12-13-day-old embryo), the cells expressing 
either the RAR@ or y gene were sorted out from each 
other (Fig. 3), i.e. the region where either the RAW or 
y gene was expressed was distinctly specific for the 
various tissues. Since the neural crest cells migrating 
from midbrain and anterior hindbrain are settled 
together in such facial regions as the lateral nasal pro- 
minences during the morphogenetic stage [16,17], and 
since they migrate probably further to the terminal area 
specific for the differentiation fate, the change in the 
expression pattern of the RAR genes can be explained 
rather simply when we assume that the fates of the 
neural crest cells, including expression of the RAR 
genes, are specified before the cells start migrating. If 
the position of the cells determined the RAR gene ex- 
pression, we cannot explain with a simple assumption, 
the occurrence of the overlapped expression of both 
RAR,& and y genes. Hence, we propose a working 
hypothesis that the differential expression of the RAR 
subtype genes correlates to the origin of the neural crest 
cells, i.e., the mesenchymal cells derived from the mid- 
brain and anterior hindbrain express the RARp and y 
genes, respectively. 
The role of RA during face development is still 
uncertain, although RA appears to be a putative mor- 
phogen working a positional cue in limb buds [1,2]. 
However, it is quite clear that the RA level in the 
developing face is an important factor for mor- 
phogenesis, because exogenous RA induces severe 
facial defects [4]. In any case, the endogenous level of 
RA and the distribution of the RARs are concluded to 
play crucial key roles during facial morphogenesis. 
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